Physician
Sacato Pediatricts PC
Sacato Pediatricts PC was paid $3.86M by Medicaid between Jan 2018 and Jul 2023, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoSACATO PEDIATRICTS PC
ARLINGTON, VA 22204
ARLINGTON, VA 22204
33aNPI1811187248assigned 08/01/2007
33bProvider typePediatrics Physician
28Total paid$3.86M
24GClaims155,094
24DCodes billed71
24AFirst – last monthJan 2018 – Jul 2023
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#44 of 817
Median peer was paid$29K
This provider vs. median132×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,095 | $764K | |
| 2019 | 33,201 | $751K | |
| 2020 | 26,834 | $622K | |
| 2021 | 24,528 | $608K | |
| 2022 | 25,119 | $721K | |
| 2023 | 14,317 | $390K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 21,660 | 18,959 | $1.24M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11% | 5,551 | 5,295 | $410K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.8% | 4,539 | 4,366 | $341K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.5% | 4,001 | 3,841 | $326K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.9% | 3,208 | 3,018 | $267K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.8% | 2,569 | 2,474 | $184K |
| 92551 | 3.4% | 14,036 | 13,325 | $129K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.0% | 3,257 | 3,076 | $114K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 7,047 | 6,492 | $94K |
| 90651 | 2.3% | 2,070 | 1,987 | $88K | |
| 90686 | 2.1% | 7,286 | 6,986 | $82K | |
| 90670 | 1.5% | 2,577 | 2,499 | $57K |
59 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 3,579 | $50K |
| 90734 | 1.1% | 1,546 | $43K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,551 | $36K |
| 99173 | <1% | 11,931 | $27K | |
| 90723 | <1% | 1,817 | $27K | |
| 90680 | <1% | 1,716 | $26K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 742 | $25K |
| 90620 | <1% | 679 | $25K | |
| 90633 | <1% | 1,856 | $23K | |
| 99188 | <1% | 1,044 | $21K | |
| 90710 | <1% | 564 | $21K | |
| 96127 | <1% | 3,462 | $16K | |
| 90648 | <1% | 1,293 | $14K | |
| 90647 | <1% | 989 | $11K | |
| 90715 | <1% | 744 | $11K | |
| 85018 | <1% | 4,573 | $11K | |
| 99177 | <1% | 2,093 | $10K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 118 | $10K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 10,785 | $10K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 578 | $9K |
| 90696 | <1% | 534 | $8K | |
| 83655 | <1% | 643 | $7K | |
| 90621 | <1% | 235 | $7K | |
| 85014 | <1% | 2,561 | $6K | |
| 90716 | <1% | 349 | $6K | |
| 90461 | <1% | 4,406 | $6K | |
| 0071A | <1% | 133 | $5K | |
| 87807 | <1% | 390 | $5K | |
| 0072A | <1% | 119 | $5K | |
| 90707 | <1% | 316 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 139 | $4K |
| 90700 | <1% | 355 | $4K | |
| 0001A | <1% | 155 | $4K | |
| 0002A | <1% | 101 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 229 | $4K |
| 81002 | <1% | 1,166 | $3K | |
| 94760 | <1% | 2,027 | $3K | |
| 97802 | <1% | 2,632 | $3K | |
| 86580 | <1% | 421 | $3K | |
| A7010 | Corrugated tubing, disposable, used with large volume nebulizer, 100 feet | <1% | 192 | $2K |
| 94010 | <1% | 57 | $2K | |
| 86328 | <1% | 35 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,401 | $999.40 |
| 87428 | <1% | 40 | $990.08 | |
| 96160 | <1% | 406 | $760.58 | |
| 0111A | <1% | 14 | $560.00 | |
| 90685 | <1% | 48 | $555.48 | |
| 69210 | <1% | 13 | $492.64 | |
| 36416 | <1% | 2,519 | $387.84 | |
| 99000 | <1% | 56 | $209.78 | |
| 99383 | <1% | 14 | $175.48 | |
| 96161 | <1% | 19 | $38.59 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 43 | $36.10 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 224 | $17.65 |
| 91300 | <1% | 275 | $1.60 | |
| 91307 | <1% | 302 | $0.61 | |
| 91311 | <1% | 20 | $0.15 | |
| 90688 | <1% | 18 | $0.13 | |
| 99401 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSACATO, MARIA (MD)